News Feb 3, 2025 Alimentiv and PhaseV Partner on Machine Learning-Based Solutions to Tackle Challenges in GI Clinical Trials February 3, 2025 – Alimentiv Inc., a global full-service GI Contract Research Organization (CRO), announced today it has entered a strategic partnership with PhaseV, a… Read Now
Article Feb 3, 2025 Connecting the Spots: How Histopathology Expertise Supports Spatial Transcriptomics Analysis The path to drug development is inherently complex. In preclinical stages of drug development, it is difficult to predict how a drug affects the heterogenous… Read Now
Article Dec 20, 2024 Advancing EoE Histopathology With Emerging AI Solutions From Alimentiv Disclaimer*The AI-based algorithm for automated PEC developed by Alimentiv is not a medical device and is not used by healthcare professionals for clinical diagnosis or… Read Now
News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Article Nov 1, 2024 Give Your Project Lift With A Proven Quality By Design Framework Applying our Quality By Design framework in clinical trials saves time, money, and resources. These are crucial, precious,… Read Now
News Oct 12, 2024 Alimentiv and Satisfai Health Extend Partnership to Accelerate Development of Innovative Imaging Technologies to Tackle GI Disease Challenges Alimentiv, a full-service GI CRO and pioneer in IBD medical imaging solutions since 1986, is excited to announce the expansion of its partnership with Satisfai… Read Now
